SCHEMBL7683098

SCHEMBL7683098

COC(=O)c1ccc(N)cc1N(C)S(C)(=O)=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.64
GAA P10253 3/20 0.54
L3MBTL1 Q9Y468 4/20 0.45
CYP19A1 P11511 1/20 0.44
HSD17B10 Q99714 5/20 0.43
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 4/20 0.43
MAPT P10636 2/20 0.43
HPGD P15428 2/20 0.43
GLA P06280 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
ATM Q13315 1/20 0.43
ABL1 P00519 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
TSHR P16473 2/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
CFTR P13569 2/20 0.39
POLB P06746 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20683121 0.88 KMT2A (0.64) KMT2AGAAL3MBTL1CYP19A1HSD17B10
SCHEMBL7555104 0.84 KMT2A (0.66) KMT2AGAAL3MBTL1HSD17B10ALDH1A1
SCHEMBL7691521 0.82 KMT2A (0.64) KMT2AL3MBTL1HSD17B10ALDH1A1KDM4E
SCHEMBL7556668 0.82 KMT2A (0.64) KMT2AL3MBTL1HSD17B10ALDH1A1KDM4E
SCHEMBL7867134 0.82 KMT2A (0.64) KMT2AGAAL3MBTL1HSD17B10ALDH1A1
SCHEMBL7552070 0.82 KMT2A (0.64) KMT2AGAAL3MBTL1HSD17B10ALDH1A1
SCHEMBL7689461 0.81 KMT2A (0.62) KMT2AGAAL3MBTL1HSD17B10ALDH1A1
SCHEMBL7554661 0.79 KMT2A (0.59) KMT2AGAAL3MBTL1HSD17B10ALDH1A1
SCHEMBL647372 0.78 KMT2A (1.00) KMT2AGAAL3MBTL1HSD17B10ALDH1A1
SCHEMBL7689981 0.78 KMT2A (0.58) KMT2ACYP19A1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020045551-A1 4-benzoyl isoxazoles derivatives and their use as herbicides MUSIL TIBOR (GB) 2002-04-18 US disclosed
US-6323155-B1 EXCELLENT LEVEL OF HERBICIDAL ACTIVITY TOGETHER WITH CROP TOLERANCE RHONE-POULENC AGRICULTURE LIMITED (GB) 2001-11-27 US disclosed
EP-0674629-B1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE POULENC AGRICULTURE (GB) 1998-07-08 EP disclosed
EP-0674629-A1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE-POULENC AGRICULTURE LTD. (GB) 1995-10-04 EP disclosed
WO-1994014782-A1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE-POULENC AGRICULTURE LTD. (GB) 1994-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020045551-A1 4-benzoyl isoxazoles derivatives and their use as herbicides CBR3, CBR1, GLRA3 KMT2A 3499/4885GAA 3363/4885L3MBTL1 2099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.